Log In
Print this Print this

ambroxol (BEL-0218)

  Manage Alerts
Collapse Summary General Information
Company Belrose Pharma Inc.
DescriptionMicroparticle-based dosage form of ambroxol
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II/III
Standard IndicationGaucher's disease
Indication DetailsTreat Type III Gaucher's disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today